Literature DB >> 33460435

Prevalence and spectrum of DICER1 mutations in adult-onset thyroid nodules with indeterminate cytology.

Anne-Sophie Chong1,2, Yuri E Nikiforov3, Vincenzo Condello3, Abigail I Wald3, Marina N Nikiforova3, William D Foulkes1,2,4,5, Barbara Rivera2,4,6.   

Abstract

CONTEXT: DICER1 mutations are found in multinodular goiter and differentiated thyroid carcinoma in children, and can be a manifestation of DICER1 syndrome, but the prevalence of DICER1 mutations and their significance in adult-onset thyroid nodules is unknown.
OBJECTIVE: Determine 1) the prevalence of DICER1 hotspot mutations in thyroid nodules; 2) the frequency of a second DICER1 pathogenic variant in thyroid nodules with DICER1 hotspot mutations; 3) the prevalence of other thyroid cancer driver mutations in thyroid nodules with and without DICER1 hotspot mutations.
DESIGN: Population-based study of 14,993 consecutive fine needle aspiration biopsies of thyroid nodules evaluated by ThyroSeq v3. From 214 DICER1 hotspot-positive cases, we selected 61, matched to DICER1 hotspot-negative nodules. We performed full sequencing of all exons and exon-intron boundaries of DICER1.
SETTING: Commercial and university-based laboratories in the United States and Canada.
RESULTS: Among 14,993 thyroid nodules, 214 (1.4%) revealed a DICER1 hotspot mutation. A second pathogenic/likely pathogenic variant in DICER1 was found in 45/59 (76%) DICER1 hotspot-positive nodules studied while no other DICER1 variant was identified in the DICER1 hotspot-negative group by full DICER1 sequencing. Other alterations in thyroid-related genes were significantly more frequent in DICER1 hotspot-negative nodules (32/61) than in DICER1 hotspot-positive nodules (4/59) (p<0.0001).
CONCLUSIONS: DICER1 alterations occur in a proportion of adult thyroid nodules and appear mutually exclusive with alterations in other thyroid cancer-related genes. DICER1 hotspot mutations occur with a second hit in most cases and could suggest occult DICER1 syndrome in adults with thyroid nodules.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  DICER1 mutation; thyroid cancer genes; thyroid nodules

Year:  2021        PMID: 33460435     DOI: 10.1210/clinem/dgab025

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors.

Authors:  Madeline Sauer; Justine A Barletta
Journal:  Head Neck Pathol       Date:  2022-03-21

2.  Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform.

Authors:  Charles A Ghossein; Snjezana Dogan; Nada Farhat; Iñigo Landa; Bin Xu
Journal:  Virchows Arch       Date:  2021-09-27       Impact factor: 4.064

3.  PUMILIO competes with AUF1 to control DICER1 RNA levels and miRNA processing.

Authors:  Swetha Rajasekaran; Eshan Khan; Samuel R Ching; Misbah Khan; Jalal K Siddiqui; Daniela F Gradia; Chenyu Lin; Stephanie J Bouley; Dayna L Mercadante; Amity L Manning; André P Gerber; James A Walker; Wayne O Miles
Journal:  Nucleic Acids Res       Date:  2022-06-23       Impact factor: 19.160

Review 4.  Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review.

Authors:  Georgios Geropoulos; Kyriakos Psarras; Maria Papaioannou; Dimitrios Giannis; Maria Meitanidou; Konstantinos Kapriniotis; Nikolaos Symeonidis; Efstathios T Pavlidis; Theodoros E Pavlidis; Konstantinos Sapalidis; Nada Mabrouk Ahmed; Tarek Ezzat Abdel-Aziz; Mohammad M R Eddama
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

5.  Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.

Authors:  Johan O Paulsson; Nima Rafati; Sebastian DiLorenzo; Yi Chen; Felix Haglund; Jan Zedenius; C Christofer Juhlin
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.